BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9344196)

  • 1. Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia.
    Baer SC; Casaubon L; Younes M
    J Am Acad Dermatol; 1997 Oct; 37(4):575-7. PubMed ID: 9344196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study on keratin expression in certain cutaneous epithelial neoplasms. Basal cell carcinoma, pilomatricoma, and seborrheic keratosis.
    Shimizu N; Ito M; Tazawa T; Sato Y
    Am J Dermatopathol; 1989 Dec; 11(6):534-40. PubMed ID: 2481408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A; Smoller BR
    Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.
    Lavrijsen AP; Tieben LM; Ponec M; van der Schroeff JG; van Muijen GN
    Arch Dermatol Res; 1989; 281(2):83-8. PubMed ID: 2476080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis].
    Sutter C; Wersin R; Varnai M; Friemann J
    Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of low-molecular-weight stress protein HSP 27 in normal skin and common cutaneous lesions.
    Gandour-Edwards R; McClaren M; Isseroff RR
    Am J Dermatopathol; 1994 Oct; 16(5):504-9. PubMed ID: 7802164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in seborrheic keratoses.
    Clemmensen OJ; Sjølin KE
    Acta Derm Venereol; 1986; 66(2):158-61. PubMed ID: 2424241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.
    Rose CL; Chakravarti N; Curry JL; Torres-Cabala CA; Bassett R; Prieto VG; Tetzlaff MT
    J Cutan Pathol; 2012 Aug; 39(8):762-8. PubMed ID: 22764884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities.
    Ginarte M; García-Caballero T; Fernández-Redondo V; Beiras A; Toribio J
    J Cutan Pathol; 2000 Jul; 27(6):276-82. PubMed ID: 10885403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.